The AJMC® Heart Failure compendium is a comprehensive resource for clinical news and expert insights for the chronic condition in which the heart doesn't pump enough blood due to damaged heart muscle.
April 17th 2024
Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders.
KCCQ-OS Better Able to Predict Changes in Health Status, Study Says
March 25th 2021After a 12-month follow-up of patients in the CHAMP-HF registry, Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OS) was shown to be more prognostically accurate compared with New York Heart Association functional class.
Read More
Patients With HFpEF Administered Sacubitril/Valsartan Gain Renal Benefits
March 4th 2021Study results from Taiwan of patients with heart failure and comorbid chronic kidney disease show a drop in the risk of renal function decline among patients with heart failure with preserved ejection fraction (HFpEF) administered sacubitril/valsartan.
Read More
Varying Physical Activity for Patients With HFpEF Fails to Increase VO2 Levels
February 27th 2021A comparison of patients with heart failure with preserved ejection fraction (HFpEF) randomized to 1 of 2 physical activities did not show a significant increase in peak oxygen consumption (VO2) vs guideline-based physical activity.
Read More
Researchers Call for Earlier Monitoring of Cardiac Function Among High-risk Patients
February 15th 2021An analysis of 30-year data on participants from the Augusta Heart study shows that Black individuals begin to exhibit potential signs of congestive heart failure earlier than their White counterparts.
Read More
Implementation of Early Follow-up Care After Heart Failure Hospitalization
An early heart failure follow-up intervention succeeded in increasing referral to and completion of cardiology appointments within 7 days of discharge. The intervention was associated with lower risk of 30-day all-cause emergency department visits, all-cause hospitalizations, or death.
Read More
Entresto Is Top HFrEF Treatment Recommendation in Updated ACC Guidelines
January 28th 2021Treatment optimization for heart failure with reduced ejection fraction is the focus of the American College of Cardiology’s 2021 update to its 2017 Expert Consensus Decision Pathway on managing patients with the condition.
Read More
Study Identifies Platelet Distribution Width as a Predictor of Heart Failure Prognosis
January 8th 2021Amid speculation that total blood counts may be associated with heart failure prognosis, researchers find that higher levels of platelet distribution width could be used to predict a worse prognosis for heart failure.
Read More